Washington Trust Advisors’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7K Sell
139
-44
-24% -$3.21K ﹤0.01% 517
2026
Q1
$11.9K Sell
183
-8
-4% -$594 ﹤0.01% 478
2025
Q4
$15.1K Sell
191
-34
-15% -$2.6K ﹤0.01% 461
2025
Q3
$16.4K Buy
225
+23
+11% +$1.69K ﹤0.01% 464
2025
Q2
$15.3K Hold
202
– – ﹤0.01% 425
2025
Q1
$15.4K Sell
202
-225
-53% -$16.8K ﹤0.01% 424
2024
Q4
$28.2K Hold
427
– – ﹤0.01% 376
2024
Q3
$29.8K Hold
427
– – ﹤0.01% 383
2024
Q2
$22.6K Buy
+427
New +$25.9K ﹤0.01% 393

Other funds holding SOLV

Washington Trust Advisors's SOLV Position: Q2 2026 in Review

Washington Trust Advisors reduced its Solventum (SOLV) stake by 24% in Q2 2026, selling an estimated $3.21K and leaving 139 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Washington Trust Advisors first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $29.8K in Q3 2024. 885 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Washington Trust Advisors held 139 shares of Solventum worth $10.7K as of Q2 2026.
  • Washington Trust Advisors sold 44 Solventum shares in Q2 2026, an estimated $3.21K.
  • Solventum made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #517 holding.
  • Washington Trust Advisors first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Washington Trust Advisors's Solventum position peaked at $29.8K in Q3 2024.
  • 885 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.